Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Am J Ophthalmol ; 131(5): 620-5, 2001 May.
Article in English | MEDLINE | ID: mdl-11336937

ABSTRACT

PURPOSE: This study reports outcomes of phacoemulsification cataract extraction and posterior chamber intraocular lens implantation within the capsular bag in patients with uveitis. METHODS: We retrospectively reviewed the charts of 32 patients (39 eyes) with uveitis who underwent phacoemulsification cataract extraction and posterior chamber intraocular lens implantation by two surgeons at The Cleveland Clinic Foundation from January 1990 to June 1998. Patients with less than 3 months of follow-up were excluded. RESULTS: Diagnoses of uveitis included idiopathic (15 eyes), sarcoidosis (10 eyes), pars planitis (four eyes), CMV retinitis (two eyes), Fuchs heterochromic iridocyclitis (two eyes), syphilis (two eyes), and one eye each of tuberculosis, Crohn's disease, HLA-B27 associated, and acute retinal necrosis. Average follow-up was 20 months (range, 3 to 63 months). Best-corrected visual acuity improved in 37 eyes (95%). Average improvement was 4 +/- 3 Snellen acuity lines (range, 1 to 10 lines). Thirty-four eyes (87%) attained final visual acuity better than or equal to 20/40. Visual loss occurred in one eye (3%) with CMV retinitis. No improvement in visual acuity was seen in one eye (3%) that developed a retinal pigment epithelial detachment. Posterior capsule opacification occurred in 24 eyes (62%), 12 of which required Nd:YAG capsulotomy (31%). Other postoperative complications included recurrence of uveitis (41%), cystoid macular edema (33%), epiretinal membrane formation (15%), and posterior synechiae (8%). CONCLUSIONS: Phacoemulsification cataract extraction with posterior chamber intraocular lens implantation is safe in patients with uveitis. The incidences of recurrence of uveitis, cystoid macular edema, epiretinal membrane, and posterior synechiae were lower than those reported previously for extracapsular cataract extraction.


Subject(s)
Cataract/complications , Lens Implantation, Intraocular , Phacoemulsification , Uveitis/complications , Adult , Aged , Cataract/therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged , Postoperative Complications , Recurrence , Retrospective Studies , Treatment Outcome , Uveitis/surgery , Visual Acuity
2.
Am J Ophthalmol ; 131(3): 390-2, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11239882

ABSTRACT

PURPOSE: To report a case of visual improvement after macular translocation performed for a subfoveal choroidal neovascular membrane in a patient with pseudoxanthoma elasticum and angioid streaks. METHODS: The fovea was translocated inferiorly by scleral imbrication, intentional retinal detachment with a small posterior retinotomy, and partial fluid-air exchange. The choroidal neovascular membrane was photocoagulated 1 week later. RESULTS: The visual acuity of the patient improved from 20/125 to 20/40. The center of the foveal avascular zone was moved inferiorly 844 microm. The choroidal neovascular membrane was extrafoveal after translocation and was treated with laser photocoagulation. CONCLUSION: Macular translocation may be considered in the management of subfoveal choroidal neovascular membrane in patients with pseudoxanthoma elasticum and angioid streaks.


Subject(s)
Angioid Streaks/complications , Choroidal Neovascularization/surgery , Fovea Centralis/surgery , Macula Lutea/transplantation , Adult , Choroidal Neovascularization/etiology , Fluorescein Angiography , Fundus Oculi , Humans , Laser Coagulation , Male , Pseudoxanthoma Elasticum/complications , Visual Acuity
4.
Am J Ophthalmol ; 129(6): 819-20, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10927004

ABSTRACT

PURPOSE: To report a case of choroidal rupture associated with forceps delivery. METHOD: Case report. RESULTS: We examined a 4-year-old boy with a history of a retinal scar in the right eye. The child was delivered with forceps and had bitemporal ecchymoses at birth. There was no other history of trauma. Ophthalmoscopic examination of the right eye with a vision of counting fingers revealed linear scars from choroidal rupture in the posterior pole, including one through the macula. Anterior segment examination was normal. Examination of the left eye was completely normal. CONCLUSION: Ocular trauma associated with forceps delivery may rarely result in choroidal ruptures, even in the absence of external signs of injury, such as breaks in Descemet membrane.


Subject(s)
Choroid/injuries , Eye Injuries/etiology , Obstetrical Forceps/adverse effects , Child, Preschool , Choroid/pathology , Eye Injuries/diagnosis , Humans , Male , Rupture
5.
Semin Ophthalmol ; 15(1): 44-50, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10749314

ABSTRACT

Tissue plasminogen activator (tPA) is a thrombolytic agent that activates plasminogen into plasmin almost exclusively in the presence of fibrin. Intraocular injection of tPA has been proposed for the treatment of vitreoretinal diseases, such as vitreous hemorrhage, postvitrectomy fibrin formation, submacular hemorrhage, retinal vascular occlusive disorders, suprachoroidal hemorrhage and endophthalmitis. Currently, intraocular tPA is only used in the treatment of postvitrectomy fibrin formation and submacular hemorrhage. For other indications, tPA has not been shown to be safe or effective. This article reviews the use of tPA in the treatment of vitreoretinal disorders.


Subject(s)
Plasminogen Activators/therapeutic use , Retinal Diseases/drug therapy , Tissue Plasminogen Activator/therapeutic use , Vitreous Body , Animals , Anterior Chamber , Eye Diseases/drug therapy , Humans , Injections , Intraoperative Period , Molecular Structure , Plasminogen Activators/administration & dosage , Plasminogen Activators/chemistry , Postoperative Period , Retina , Retinal Diseases/surgery , Tissue Plasminogen Activator/administration & dosage , Tissue Plasminogen Activator/chemistry , Treatment Outcome , Vitrectomy
6.
Am J Ophthalmol ; 128(2): 135-46, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10458168

ABSTRACT

PURPOSE: To conduct a prospective study of macular translocation in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration. METHODS: In 10 eyes of 10 patients with subfoveal choroidal neovascularization and best-corrected visual acuity ranging from 20/50 to 20/800 (median, 20/111), the fovea was relocated by means of scleral imbrication, intentional retinal detachment with small posterior retinotomies, and partial fluid-air exchange. In two eyes, the choroidal neovascular membranes were removed at the time of macular translocation; in seven eyes they were photocoagulated in the postoperative period; and in one eye the membrane was removed during reoperation to unfold a macular fold. RESULTS: All 10 eyes were followed up for 6 months. The median postoperative foveal displacement was 1286 microm (range, 114 to 1,919 microm). In three eyes (30%), a foveal fold formed postoperatively requiring reoperation, with one of these eyes requiring a second reoperation for a rhegmatogenous retinal detachment. Best-corrected visual acuity improved in four eyes (median, 10.5 letters) and decreased in six eyes (median, 14.5 letters). The median change in visual acuity was a decrease of 5 letters. The final best-corrected visual acuity was 20/80 in two eyes, 20/126 in one eye, 20/160 in four eyes, 20/200 in one eye, 20/250 in one eye, and 20/640 in one eye. CONCLUSIONS: Our initial experience with limited macular translocation suggests that this surgical technique is unpredictable. However, in patients with subfoveal choroidal neovascularization from age-related macular degeneration, it offers the potential for improving visual function and may be associated with less loss of vision than the disease itself, if allowed to progress. Further refinements in surgical indications and technique are needed to make this procedure safer, more predictable, and more beneficial.


Subject(s)
Choroidal Neovascularization/surgery , Macula Lutea/transplantation , Macular Degeneration/complications , Ophthalmologic Surgical Procedures/methods , Aged , Aged, 80 and over , Choroidal Neovascularization/diagnosis , Choroidal Neovascularization/etiology , Female , Fluorescein Angiography , Follow-Up Studies , Fovea Centralis/pathology , Fundus Oculi , Humans , Macular Degeneration/diagnosis , Macular Degeneration/surgery , Male , Prospective Studies , Treatment Outcome , Visual Acuity
7.
Ophthalmology ; 105(9): 1765-9, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9754189

ABSTRACT

OBJECTIVE: The objective of the study was to determine the long-term outcome of patients with uveitis who underwent extracapsular cataract extraction (ECCE) and posterior chamber intraocular lens (PCIOL) implantation. DESIGN: Retrospective review. PARTICIPANTS: Twenty-eight patients (36 eyes). INTERVENTION: Extracapsular cataract extraction and PCIOL implantation. MAIN OUTCOME MEASURES: Level of best-corrected Snellen visual acuity, change in visual acuity, length of follow-up, long-term findings, and complications. RESULTS: In long-term follow-up (mean, 81.4 months), 94% of eyes had visual acuity improvement compared with preoperative levels. Average change in visual acuity for all eyes was an improvement of 6.4 Snellen lines; 75% of eyes were 20/40 or better. The prevalences of cystoid macular edema (CME), epiretinal membrane (ERM), and posterior capsule opacification (PCO) were 56%, 56%, and 58%, respectively. CONCLUSIONS: Patients with uveitis who are treated with ECCE with PCIOL implantation can have successful visual results in long-term follow-up despite the prevalence of PCO or macular abnormalities such as CME and ERM.


Subject(s)
Cataract Extraction , Cataract/complications , Lens Implantation, Intraocular , Uveitis, Anterior/complications , Uveitis, Posterior/complications , Female , Follow-Up Studies , Humans , Lenses, Intraocular , Male , Polymethyl Methacrylate , Postoperative Complications , Retrospective Studies , Visual Acuity
8.
Anesth Analg ; 79(1): 165-71, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8010430

ABSTRACT

Both epidural and general anesthetics alter autonomic balance. However, the relative differences between epidural (EA) and general anesthetics (GA) with regard to cardiac and peripheral sympathovagal balance have not been described. Twenty consecutive patients scheduled for radical retropubic prostatectomy were randomized to receive EA (n = 10) or GA (n = 10). Power spectral analysis was performed on the electrocardiographic recordings, with the ratio of low (0.05-0.125 Hz)/high (0.125-0.5 Hz) frequency power used an index of cardiac sympathovagal balance. The forearm minus fingertip skin-surface temperature gradient (> 4 degrees C) was used as an indicator of sympathetically mediated peripheral vasoconstriction. Patients in the EA group demonstrated a significantly greater low/high frequency power ratio and a more frequent incidence of peripheral vasoconstriction than the GA group during the intraoperative period. During the postoperative period, the GA group demonstrated an increase in the low/high ratio and the incidence of vasoconstriction relative to the intraoperative period. Intraoperatively, upper body vasoconstriction appears to be accompanied by a significant shift in cardiac sympathovagal balance toward sympathetic predominance with EA relative to GA. Postoperatively, GA is associated with a shift in the sympathovagal balance toward sympathetic predominance. Further research is required to determine whether this results in cardiovascular compromise in the high-risk patient.


Subject(s)
Anesthesia, Epidural , Anesthesia, General , Heart/innervation , Vasoconstriction/physiology , Electrocardiography , Heart/physiology , Humans , Male , Middle Aged , Prostatectomy , Sympathetic Nervous System/physiology , Vagus Nerve/physiology
9.
J Neuroimmunol ; 45(1-2): 31-6, 1993 Jun.
Article in English | MEDLINE | ID: mdl-8331163

ABSTRACT

Borna disease virus (BDV) establishes a persistent infection in cells of the nervous system in rats. The response, or lack thereof, of the immune system to BDV infection of neurons is responsible for the presence or absence, respectively, of Borna disease. We recently demonstrated transmission of BDV by bone marrow cells from neonatally infected rats. Our findings suggested the possibility of a heretofore unsuspected interaction between BDV and the immune system, that of direct effects of BDV infection on the cells of the immune system. This report enlarges upon the previous findings and confirms the presence of BDV RNA in bone marrow cells of neonatally infected rats, using a reverse transcription-polymerization chain reaction-enzyme immunosorbent assay (RT-PCR-EIA). In addition, we detected BDV RNA in peripheral blood mononuclear cells of neonatally infected rats, and in rats inoculated as adults in the chronic, but not the acute, stage of infection. In addition, the RT-PCR-EIA technique identified BDV RNA in cerebrospinal fluid, nasal secretions, saliva, urine and stool. BDV-sequences were not detected in the plasma of infected animals nor in the body fluids and tissues of normal rats.


Subject(s)
Bone Marrow/microbiology , Borna Disease/microbiology , Borna disease virus/isolation & purification , Monocytes/microbiology , Aging , Animals , Animals, Newborn , Base Sequence , Bone Marrow/pathology , Borna Disease/pathology , Chronic Disease , Immunoenzyme Techniques , Molecular Probes/genetics , Molecular Sequence Data , Polymerase Chain Reaction , RNA, Viral/analysis , Rats , Rats, Inbred Lew , Transcription, Genetic
10.
J Cardiothorac Vasc Anesth ; 6(6): 651-7, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1361865

ABSTRACT

Extensive changes in hemodynamics and cardiac rhythm during induction of anesthesia may be mediated by altered responses of the autonomic nervous system to anesthetic agents. Analysis of the power spectrum of the heart rate (PSHR) variability can supply information about the autonomic nervous system, and may be used in order to assess this phenomenon. In this study, 78 patients undergoing coronary artery bypass graft surgery were evaluated. Anesthesia was induced with sufentanil, and neuromuscular blockade with vecuronium, a combination that may cause a decrease in heart rate. Before and after induction of anesthesia, the heart rate (HR), blood pressure (BP), cardiac output (CO), cardiac index (CI), and PSHR components were recorded. PSHR was obtained by using a special algorithm and data acquisition system for real-time spectral analysis. A low-frequency component (LFa, mainly sympathetic) was analyzed from a band of 0.04 Hz to 0.1 Hz. A high-frequency component (RFa, parasympathetic) was identified by the respiratory frequency spectrum. Alterations of the heart rate after induction of anesthesia were defined in order to separate the patient population into two groups: slow heart rate (slow-HR) and stable heart rate (stable-HR). Slow heart rate was defined as a decrease in HR of more than 20% of the baseline value. The variables were analyzed and compared between the slow-HR (n = 25) and stable-HR (n = 53) groups in order to verify the possibility of identifying patients prone to hemodynamic changes after anesthesia induction. There were no differences in preoperative HR, BP, CO, or CI between groups before anesthesia induction.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Anesthesia, Intravenous , Autonomic Nervous System/drug effects , Heart Rate/drug effects , Hemodynamics/drug effects , Sufentanil/pharmacology , Adult , Aged , Autonomic Nervous System/physiology , Blood Pressure/drug effects , Blood Pressure/physiology , Bradycardia/physiopathology , Cardiac Output/drug effects , Cardiac Output/physiology , Central Venous Pressure/drug effects , Central Venous Pressure/physiology , Electrocardiography/drug effects , Female , Heart Rate/physiology , Hemodynamics/physiology , Humans , Male , Middle Aged , Respiration/drug effects , Respiration/physiology , Stroke Volume/drug effects , Stroke Volume/physiology , Sufentanil/administration & dosage , Vecuronium Bromide/administration & dosage , Vecuronium Bromide/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...